Edition:
United States

Transgene SA (TRNG.PA)

TRNG.PA on Paris Stock Exchange

2.99EUR
17 Aug 2018
Change (% chg)

€-0.05 (-1.64%)
Prev Close
€3.04
Open
€2.99
Day's High
€3.04
Day's Low
€2.99
Volume
12,900
Avg. Vol
59,849
52-wk High
€3.79
52-wk Low
€2.40

Select another date:

Thu, Apr 26 2018

BRIEF-Transgene Q1 Operating Revenue Stable At 1.8 Million Euros

* TRANSGENE: €35.6 MILLION IN CASH AND CASH EQUIVALENTS AS OF MARCH 31, 2018

BRIEF-Transgene Says PCPV Most Promising Therapeutic Candidate Amongst Evaluated Poxviridae

* PCPV WAS FOUND TO BE MOST PROMISING THERAPEUTIC CANDIDATE AMONGST POXVIRIDAE EVALUATED BY TRANSGENE Source text for Eikon: Further company coverage: (Gdynia Newsroom)

BRIEF-Transgene To Announce Major Clinical Results In 2018

* TRANSGENE TO ANNOUNCE MAJOR CLINICAL RESULTS IN 2018 AND ACHIEVE PROMISING PROGRESS ON ITS NEW ONCOLYTIC VIRUSES

Select another date: